Betz Stephen F.

Chief Scientific OfficerCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Sep 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
13
2 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2026Disposed to issuer(D)58K$85.00$5.0M80K
Sep 1, 2026Disposed to issuer(D)80K$85.00$6.8M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2026Disposed to issuer(D)91K$83.09$7.5M0
Sep 1, 2026Disposed to issuer(D)75K$75.72$5.6M0
Sep 1, 2026Disposed to issuer(D)56K$59.81$3.4M0
Sep 1, 2026Disposed to issuer(D)60K$62.39$3.7M0
Sep 1, 2026Disposed to issuer(D)85K$69.71$5.9M0
Sep 1, 2026Disposed to issuer(D)15K$61.81$927K0
Sep 1, 2026Disposed to issuer(D)77K$64.98$5.0M0
Sep 1, 2026Disposed to issuer(D)110K$65.36$7.2M0
Sep 1, 2026Disposed to issuer(D)87K$41.49$3.6M0
Sep 1, 2026Disposed to issuer(D)65K$48.14$3.1M0
Sep 1, 2026Disposed to issuer(D)47K$41.21$1.9M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-059884) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.